We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| (MM) | NASDAQ:DARA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.88 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
WAYNE, Pa., June 11, 2015 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of DARA BioSciences, Inc. ("DARA" or the "Company") (NASDAQ: DARA) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Midatech Pharma PLC ("Midatech").
If you own shares of DARA and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/dara. You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com.
Under the terms of the agreement, shareholders of DARA will receive (i) 0.272 Ordinary Shares of Midatech, subject to certain adjustments described in more detail below, and (ii) one Contingent Value Right ("CVR"). All Midatech Ordinary Shares will be delivered to the holders of DARA Common Stock in the form of American Depositary Receipts ("ADRs").
Our investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of DARA for not acting in the Company's shareholders' best interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. To learn more about the class action process, please visit: www.rmclasslaw.com.
CONTACT: Ryan & Maniskas, LLP
Richard A. Maniskas, Esquire
995 Old Eagle School Rd., Suite 311
Wayne, PA 19087
877-316-3218
www.rmclasslaw.com/cases/dara
rmaniskas@rmclasslaw.com
Logo - http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ryan--maniskas-llp-investigation-of-dara-biosciences-inc-300097797.html
SOURCE Ryan & Maniskas, LLP
Copyright 2015 PR Newswire
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
